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Background: Acute mesenteric ischemia is a life-threatening vascular emergency resulting in tissue destruction
due to ischemia-reperfusion injury. Melatonin, the primary hormone of the pineal gland, is a powerful scavenger
of reactive oxygen species (ROS), including the hydroxyl and peroxyl radicals, as well as singlet oxygen, and nitric
oxide. In this study, we aimed to investigate whether melatonin prevents harmful effects of superior mesenteric
ischemia-reperfusion on intestinal tissues in rats.
Methods: Rats were randomly divided into three groups, each having 10 animals. In group I, the superior mesenteric
artery (SMA) was isolated but not occluded. In group II and group III, the SMA was occluded immediately distal to the
aorta for 60 minutes. After that, the clamp was removed and the reperfusion period began. In group III, 30 minutes
before the start of reperfusion, 10 mg/kg melatonin was administered intraperitonally. All animals were sacrified
24 hours after reperfusion. Tissue samples were collected to evaluate the I/R-induced intestinal injury and bacterial
translocation (BT).
Results: There was a statistically significant increase in myeloperoxidase activity, malondialdehyde levels and in the
incidence of bacterial translocation in group II, along with a decrease in glutathione levels. These investigated
parameters were found to be normalized in melatonin treated animals (group III).
Conclusion: We conclude that melatonin prevents bacterial translocation while precluding the harmful effects of
ischemia/reperfusion injury on intestinal tissues in a rat model of superior mesenteric artery occlusion.
Keywords: Melatonin, Ischemia-reperfusion, Bacterial translocationBackground
Acute mesenteric ischemia (AMI) is a life-threatening
vascular emergency with an overall mortality of 60% to
80%, and besides its potential fatality, the incidence of
this challenging surgical problem is reported to be in-
creased [1]. Appropriate management of AMI requires
early diagnosis and rapid intervention with therapeutic
methods that adequately restore mesenteric blood flow
to prevent bowel necrosis [2]. The estimated proportion
of common forms of acute mesenteric ischemia is ap-
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unless otherwise stated.embolism, followed by SMA thrombosis (25%), non-
occlusive mesenteric ischaemia (20%) and mesenteric
venous thrombosis (5%) [3]. Irrespective of the form of
the mesenteric ischemia, the consequences are similar
and include a range of intestinal tissue damage from
mild disturbances in bowel function to transmural ne-
crosis and gangrene [1]. This tissue destruction due to
occlusion of mesenteric blood flow is often the result of
cellular injury related to reperfusion following thera-
peutic interventions [4].
While short periods of mesenteric ischemia contribute
to a mild increase in microvascular permeability, sustained
ischemia and succeeding reperfusion results in disruption
of the intestinal mucosal barrier, mainly due to generation
of toxic oxygen free radicals, such as superoxide, peroxide,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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through lipid peroxidation [2]. The injured intestinal
mucosa loses its resistance to indigenous enteric mi-
croorganisms, which leads to translocation of bacteria to
extraintestinal sites such as mesenteric lymph nodes, liver,
spleen, and blood [5]. This bacterial translocation may
play an important role in the development of sepsis and
multiple organ system failure [1].
The role of oxygen free radicals in reperfusion injury
is demonstrated by the reduction of tissue damage in the
presence of antioxidants and free-radical scavenging sub-
stances such as N-acetylcysteine, selenium, vitamins E
and C, superoxide dismutase, and catalase [1]. Melatonin
(N-acetyl-5-methoxytryptamine), the primary hormone of
the pineal gland, is a powerful scavenger of reactive oxy-
gen species (ROS), including the hydroxyl and peroxyl
radicals, as well as singlet oxygen, and nitric oxide [6]. In
addition to scavenging ROS, melatonin stimulates the
antioxidant enzymes superoxide dismutase, glutathione
peroxidase, and catalase [7,8]. Recently, several authors
have described melatonin as one of the most effective an-
tioxidants and scavengers of oxygen-free radicals after IR
injury of the liver, lung, and intestine [8,9]. In this study,
we aimed to investigate whether melatonin precludes bac-
terial translocation after intestinal ischemia-reperfusion
injury in rats.
Methods
Male Wistar-Albino rats weighing 250-300 g were used in
this study. All animals were housed in a light-controlled
room with a 12 hours light/dark cycle and were allowed
free access to food and water. Animals were housed in the
animal facility for at least 7 day prior to use to stabilize
their intestinal flora. The operative procedure, use of
anesthesia, and animal care methods in the experiments
were consistent with the National Institutes of Health
Guidelines on the Care and Use of Laboratory Animals
(NIH publication No.86-23, revised 1985, Bethesda, MD)
and also approved by the Experimental Animal Committee
of Pamukkale University School of Medicine.
Operative details
After fasting overnight, the rats were anesthetized by an
intramuscular injection of ketamine 50 mg/kg (Ketalar;
Parke Davis, Eczacibasi, Istanbul, Turkey) and xylazine
10 mg/kg (Rompun; Bayer AG, Leverkusen, Germany).
Animals were allowed to breathe spontaneously during
the surgery. A heating lamp was used to preserve the
body temperature at approximately 37°C. At the end of
the operation, 10 ml Ringer’s Lactated solution was ad-
ministered subcutaneously, to prevent dehydration of the
rats. The abdomen was shaved and twice soaked with 10%
povidone-iodine solution before rats were aseptically oper-
ated using sterile instruments. After a midline laparotomy,the superior mesenteric artery (SMA) was exposed. At this
stage of the experiment, rats were randomly divided into
three groups, each having 10 animals. In group I (sham
operated group), the superior mesenteric artery (SMA)
was isolated but not occluded. In group II (intestinal I/R
only group) and group III (intestinal I/R +melatonin
treated group), the SMA was gently isolated, and occluded
immediately distal to the aorta with collateral interruption
for 60 minutes with atraumatic microvascular clamps as
described elsewhere [10]. This procedure provided ische-
mia in small intestine, cecum and right colon which was
confirmed when the mesenteric pulsation was lost and the
intestines became pale. After 60 minutes of ischemia, the
clamp was removed and the reperfusion period began. In
group III, 30 minutes before the start of reperfusion,
10 mg/kg melatonin was administered intraperitonally.
Subsequently, the abdominal incisions were closed in two
layers with 3/0 polyglactin suture (Vicryl, Ethicon, UK).
Animals were fed with standard rat chow and water post-
operatively. All animals were anesthetized and euthanized
24 hours after reperfusion. Tissue samples were collected
to evaluate the I/R-induced intestinal injury and bacterial
translocation (BT). Using sterile technique and instru-
ments, a midline laparotomy was performed to yield biop-
sies of liver, spleen, mesenteric lymph nodes, terminal
ileum for quantitative culture of aerobic and anaerobic
organisms. A 1 ml sample of blood from vena cava was
taken and cultured in appropriate media for aerobic and
anaerobic organisms. The segments of ileum were re-
moved and frozen in liquid nitrogen and stored at –80°C
for further biochemical analysis of lipid peroxidation, mye-
loperoxidase activity, and tissue glutathione (GSH) levels,
and were also fixed in 10% formaldehyde solution for fur-
ther histo-pathological examination.
Microbiological analysis
Microbiological analysis was performed as described previ-
ously [11]. Blood (0.5 mL) samples were cultured in 5 mL
of brain heart infusion broth for 7 days at 37°C. The cul-
tures were inspected daily and subcultured on blood agar
and eosine methylene blue (EMB) agar plates. Samples of
mesenteric lymph nodes, liver, spleen and ileal contents
were weighed and placed in a sterile grinding tube. Tissues
were homogenized in 1 mL of saline for quantitative cul-
tures. This preparation was plated on blood agar and
EMB agar and was incubated at 37°C for 24-48 h in ambi-
ent air. The identification of bacterial species was per-
formed by standard microbiologic methods. Colonization
was expressed as the number of colony-forming units
(CFU) per gram of tissue homogenate (CFU/g).
Histopathological examinations
The sections of ileum embedded in Paraffin and they were
stained with hematoxylin and eosin (H & E). A pathologist
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tions under a light microscope. Intestinal mucosal lesions
were graded on a scale from 0 to 5 as described by
Chiu et al. [12]: grade 0, normal mucosal villi; grade
1, development of subepithelial Gruenhagen’s space, usu-
ally at the apex of the villus, often with capillary conges-
tion; grade 2, extension of the subepithelial space with
moderate lifting of the epithelial layer from the lamina
propria; grade 3, massive epithelial lifting with a few de-
nuded villi; grade 4, denuded villi with exposed dilated
capillaries; and grade 5, digestion and disintegration of
lamina propria, hemorrhage, and ulceration.Estimation of neutrophil accumulation
The levels of myeloperoxidase (MPO) activity in the seg-
ment of ileum were determined as an indicator of neutro-
phil accumalation. Tissues were homogenized in 50 mM
phosphate buffer (pH 7.4) (1/10, w/v) containing protease
inhibitor, 0.2 μM phenylmethanesulphonyl fluoride (PMSF)
and 1 mM Ethylenediamin tetra acetic acid (EDTA), at
4°C for 30 s using a homogenizer (Potter S, B. Braun,
Germany). Then, appropriate volume of homogenate
was used MPO determination.
The method of Suzuki et al. was used with a slight
modification [13]. This method is based on the oxidation
of the synthetic substrate 3,3’,5,5’-tetramethyl benzidine
(TMB) by MPO. The standard reaction mixture consisted
of 500 μl detergent-containing buffer (160 mM potassium
phosphate buffer, pH 5.4, 1% hexadecyltrimethylammonium
bromide), 100 μl TMB (16 mM, dissolved in dimethylfor-
mamid), 50 μl homogenate and 300 μl water. The re-
action was started by the addition of 50 μl H2O2
(diluted 0.003%) at 37°C. The rate of MPO-catalyzed
oxidation of TMB was followed by recording the in-
crease in absorbance at 655 nm. Considering the ini-
tial and linear phase of the reaction, we measured the
absorbance change per minute, and one enzyme unit
was defined as the amount of enzyme producing one
absorbance change per minute under assay conditions.
Enzyme activity was calculated as units per gram of
wet weight tissue.Determination of lipid peroxidation
The levels of malondialdehyde (MDA) in ileal tissue speci-
mens were determined as an indicator of lipid peroxida-
tion. The MDA production and hence lipid peroxidation
were assessed in the tissues by the method of Ohkowa.
MDA forms a colored complex in the presence of TBA,
which is detectable by measurement of absorbance at
532 nm. Absorbance was measured with Shimadzu
UV-160 spectrophotometer. 1,1′,3,3′ -Tetraethoxypropane
was used as a standard and the results were expressed in
tissue as μmol/g protein [14].Determination of glutathione
The concentrations of glutathione (GSH) in tissue samples
were measured by the method of Ellman [15]. One ml tis-
sue homogenate precipitated by 2 ml of 5% TCA was
taken and 0.5 ml of Ellman’s reagent (0.0198% DTNB in
1% sodium citrate) and 3 ml of phosphate buffer (pH 8.0)
were added. The color developed was read at 412 nm. The
concentration was expressed in mg/g protein in tissue
samples.
Statistics
The results were expressed as mean ± SEM. Statistical
evaluation for proportional comparisons for positive cul-
tures of tissues was made with Chi-square (Fisher’s Exact
test) analysis. Comparisons for quantitative culture and
ileal MDA, MPO, GSH levels were analyzed with Kruskal-
Wallis test, and multiple comparisons between the groups
were performed with Mann Whitney-U test. Differ-
ences were considered statistically significant when P <0.05.
Data were analyzed by statistical software (SPSS for
Windows 11.5; SPSS, Chicago, Illinois).
Results
All of the animals survived the experiment period. We
did not observe any side effect that can be attributable
to melatonin during the study period.
Bacterial translocation
The incidence of bacterial translocation to the mesen-
teric lymph nodes (MLN) (P = 0.0001), liver (P = 0.008),
and spleen (P = 0.036) was significantly higher in I/R only
animals (group II) than in sham operated and melatonin
treated animals (groups I and III) (Table 1). Furthermore,
the incidence of translocation was not statistically differ-
ent in melatonin treated group from the value measured
in sham operated group of animals for each location (P =
0.14 for MLN, P = 0.14 for liver, P = 1.00 for spleen). Bac-
terial translocation to blood was seen in only one animal
that belongs to group II. The most common translocated
microorganisms were Escherichia coli, klebsiella spp and
enterobacter spp.
Ileal bacteria counts
Ileal counts of bacteria in sham operated group were sig-
nificantly less from I/R and I/R +melatonin groups (P =
0.0001). Furthermore, melatonin treatment provided a sig-
nificant reduction in ileal bacteria count in group III than
in group II (I/R only) animals (P = 0.028) (Table 2).
Histopathological examinations
In sham-operated animals (Group I), histopathological
examinations of ileal epithelium and mucosal villi were
normal. The specimens from this group were classified
as grade 0–1 according to the Chiu’s intestinal mucosal
Table 1 Incidence and number of bacterial translocation in tissue specimens
Groups (n = 10) MLNs iIncidence CFU ± SEM Liver incidence CFU ± SEM Spleen incidence CFU ± SEM
Sham 0/10 - 0/10 - 0/10 -
I/R 8/10* 54050 ± 15315.65 6/10** 1075.5 ± 623.24 3/10*** 80 ± 46.66
I/R +melatonin 2/10 3600 ± 2993.32 2/10 250 ± 200,69 2/10 -
(*P = 0.0001, **P = 0.008, ***P = 0.036 I/R versus Sham and I/R +melatonin).
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1–4 histopathological damage was detected. In I/R +
melatonin treated Group III, grade 0–2 damage was de-
tected. The median intestinal mucosal injury score in
I/R-only Group II was significantly higher than that
in sham-operated rats (Group I) (P = 0.0001), and also
than that in melatonin-treated rats (Group III) (P = 0.003)
(Table 3). In addition, the improvement in the intestinal
mucosal injury score in I/R +melatonin-treated rats
reached the same level for that of sham-operated Group I
(P = 0.053) (Table 3). These results show that melatonin
treatment significantly attenuated the intestinal mucosal
villous injury.
Effects of melatonin on tissue neutrophil accumulation
When compared to sham group and I/R +melatonin group,
group II rats exhibited a significant increase in the ileal tis-
sue levels of MPO (P = 0.003). Treatment of rats with
melatonin in group III resulted in a significant decrease in
the levels of MPO in the ileal tissue (P = 0.013, group III
vs group II, Figure 1).
Effects of melatonin on intestinal ischemia reperfusion
GSH levels
The amount of GSH measured in intestinal tissues sub-
jected to I/R injury alone was significantly reduced when
compared to that in group I (sham) and I/R +melatonin
groups (P = 0.003, Figure 2).
Administration of melatonin significantly ameliorated
the decreased amount of GSH (P = 0.01 group II vs group
III). The amount of GSH in group III (I/R +melatonin)
was not different statistically from the value measured in
the control group (P = 0.406).
MDA levels
The mean ileal tissue MDA levels were statistically dif-
ferent among the groups (P = 0.002, Figure 3). The mean
MDA concentration in the intestinal tissue in group IITable 2 Ileal bacteria counts
Groups Ileal bacteria count
Sham 60200 ± 13573.50*
I/R 419500 ± 49857.85
I/R =melatonin 247500 ± 48369.24
(*p = 0.0001).was significantly higher than that in groups I and III
at the end of the experiment. The amount of MDA
in group III (I/R +melatonin) was not different statis-
tically from the value measured in the sham operated
group (P = 0.406).
Discussion
According to the results of the present study, melatonin,
the primary hormone of the pineal gland prevented in-
testinal bacterial translocation which was induced by mes-
enteric ischemia-reperfusion injury. This beneficial effect
of melatonin seemed to be due to the ability of this agent
to function as an intracellular scavenger of radical oxygen
species (ROS) demonstrated by a reduction in the degree
of lipid peroxidation, neutrophil accumulation and main-
taining of GSH in ileal tissue specimens.
Physiologically, intestinal barrier function is composed
of mucosal immunity and physical integrity [16]. The
main mission of the epithelium overlying mucosal surfaces
of the intestinal tract is providing an effective barrier to
the microorganisms present in the intestinal lumen. How-
ever, it has become obvious recently that the epithelial
layer is much more than a simple physical barrier [16].
The process of accomodating the microorganisms involves
various host defence mechanisms which have evolved to
regulate the composition of the them, and protection
against infection and colonisation. The primary mediators
of this activity are various anti-microbial peptides that are
secreted by the epithelium and the mucus layer that coats
the lumen. Below the mucus layer, the epithelial cells sepa-
rated by junctions that represent binding of tight junction
proteins [16]. The most abundant constituents of epithe-
lial cellular membranes are phospholipids. When phos-
pholipids are dispersed in water, they spontaneously form
lipid bilayers. The lipid bilayer serves as a matrix for
embedded proteins, which function as transporters,
ion channels, receptors for hormones and neurotrans-
mitters, etc. After ischemia/reperfusion injury, the oxygen
radicals which are the products of this oxidative stress,
destroys these lipid bilayers via lipid peroxidation [6].Table 3 Intestinal mucosal injury scores of the groups
Sham I/R I/R + Tempol
Intestinal mucosal injury scores 0 (0-1) 2 (1-4) 0 (0-2)*
Results were given as median (min-max).
(*P = 0, 3 versus I/R only Group II, P = 0, 053 versus sham-operated Group I).
Figure 1 Tissue MPO levels. Figure 3 Tissue MDA levels.
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tinal barrier function fails due to destruction of endothe-
lial and epithelial cells resulting in breakdown of mucosal
integrity [17]. Finally, indigenous enteric bacteria translo-
cate to extraintestinal sites such as mesenteric lymph
nodes, liver, spleen, and blood, resulting in sepsis and mul-
tiple organ system failure [17]. Since melatonin reduces
lipid peroxidation in every cell and tissue, it was assumed
that, in doing so, this hormone would also maintain cell
membranes in a state of optimal fluidity and membraneFigure 2 Tissue GSH levels.rigidity [6]. Moreover, it has recently reported that deriva-
tives of melatonin that are formed when the indoleamine
functions as a scavenger may actually be more effective
than melatonin itself in neutralizing the peroxyl radicals
[18]. In our study, we observed a significantly reduced
incidence of bacterial translocation to the blood, liver,
spleen, and mesenteric lymph nodes in animals pre-
treated with melatonin in an acute mesenteric ischemia/
reperfusion model. Furthermore, melatonin treatment
provided a statistically significant reduction in ileal bacter-
ial overgrowth. It was previously shown that mesenteric
ischemia/reperfusion not only produces mucosal damage
but also induces alterations of intestinal motor activity
with a delay in gastrointestinal transit time [19]. These
alterations can be the result of structural and neur-
onal changes occurring within the enteric nervous sys-
tem which may play a role in the progress of bacterial
overgrowth with subsequent translocation due to inad-
equate bacterial clearance [20]. In addition to its prop-
erties against I/R oxidative injury, melatonin has been
suggested to act as a local regulator of gastrointestinal
motility [21].
The administration of melatonin significantly decreased
the histological damage (Table 3) and PMNs infiltration in
intestinal tissue specimens in our study when compared
with the I/R only group of animals (Group II). In a
previous study, melatonin has been found to reduce
histological signs of intestinal injury in rats subjected to
splanchnic artery occlusion shock [22]. Melatonin also re-
duces the migration of PMNs into the inflammatory site
[22]. This effect of melatonin seems probably secondary
to the protection of intestinal mucosa to endothelial
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thelial barrier function. Myeloperoxidase activity, one
of the markers of neutrophil accumulation, was found
to be elevated in intestinal I/R injury [23]. In our experi-
ment, the reduction in neutrophil accumulation shown by
a significant decrease in MPO activity within the ileal tis-
sue of melatonin-treated group of animals is also seems to
be secondary to the prevention of oxidative damage. The
systemic activation of neutrophils after reperfusion ap-
pears to be secondary to mediators such as cytokines and
ROS [24]. This activated neutrophils further promotes in-
flammation and oxidative damage. It was reported that
this vicious cycle among I/R injury, endothelial damage,
and neutrophil infiltration causes additional ROS produc-
tion [25]. Previously, research has also demonstrated mel-
atonin’s anti-inflammatory properties via down-regulation
of proinflammatory cytokines [26]. The inhibitory effect of
melatonin against PMN infiltration was also observed in
another study in which oxidative stress was induced by is-
chemia and reperfusion [22]. When considered together
with our findings, it seems that melatonin treatment ef-
fectively prevents I/R related intestinal injury by interfer-
ing with this vicious cycle.
Intestinal ischemia is a life-threatening abdominal emer-
gency. The common clinical feature of the disease is
caused by impaired blood perfusion of the intestine and
the hypoxia associated sequelae, like bacterial transloca-
tion as well as local and systemic inflammation [1]. Thus,
rapid restoration of mesenteric blood flow with reoxygen-
ation of the ischemic tissue is critical to its salvage, but it
may paradoxically exacerbate tissue damage [3]. During is-
chemia, there is an increase in microvascular permeability,
release of lysosomal hydrolases and enhance in proteolysis
[19]. Those alterations are aggravated by reperfusion, since
it triggers the accumulation of free radicals, which attack
and damage the cellular membranes, attract neutrophils,
and stimulate the release of inflammatory mediators [17].
So in the clinical scenario of a patient suffering from acute
mesenteric ischemia, a potentially therapeutic agent that
is expected to block the deleterious effects of reperfusion
such as release of free oxygen radicals, should be given be-
fore restoring the arterial flow. Therefore in our experi-
mental model, melatonin was administered 30 minutes
before the start of reperfusion in the treatment group
(Group III), aiming that it is existed in circulation of the
animal. Adverse effects of melatonin are few and it is
generally regarded as safe in recommended dosages.
There are isolated case reports of psychomotor distur-
bances (disorientation, fatigue, headache, dizziness, etc.),
increased seizure risk, and blood clotting abnormalities
associated with melatonin alone or in combination with
other medications [27]. In experimental studies, melatonin
doses up to 800 mg/kg failed to cause death in mice [6]. A
lethal dose in 50% of mice, that is, LD50, has not beendetermined [6]. In humans, for most non-sleep related
disorders, doses from 10-50 mg daily have been used
safely and effectively [27]. We used a 10 mg/kg melatonin
dosage in our study 30 minutes before reperfusion starts
like other researchers did in experimental ischemia/reper-
fusion rat model investigations of melatonin [7,9,26]. It
seems to be a reasonable amount and timing when the
relatively short serum half-life (30-60 minutes) and the
total amount of melatonin in the gastrointestinal tractus
(up 400 times more than in the pineal gland) taken into
account [27,28].
Numerous mechanisms have been implicated in the
evolution and development of intestinal I/R injury. These
are overproduction of reactive oxygen species, increased
expression and infiltration of leukocytes, and production
of inflammatory mediators such as cytokines [5]. Evidence
has accumulated that melatonin is both a direct free rad-
ical scavenger and an indirect antioxidant because of its
ability to promote the activities of a variety of antioxida-
tive enzymes [29]. While it is clearly a lipid soluble agent,
it seems also capable of entering the aqueous environ-
ments of the cell which allows melatonin to be protective
of membranes from free radical damage [6]. ROS and
other free oxygen radicals are believed to cause cellular
injury and further necrosis via different mechanisms
including especially peroxidation of cellular membrane
lipids [5]. It has been previously showed in a rat model of
splanchnic artery occlusion and reperfusion that mela-
tonin treatment abolished the increase in lipid peroxida-
tion products, probably in part by scavenging the very
reactive hydroxyl and peroxyl radicals [22]. In this current
experimental model, the occlusion of superior mesenteric
artery followed by reperfusion resulted in a considerable
increase in the ileal tissue levels of malondialdehyde, and
melatonin treatment significantly prevented lipid peroxi-
dation, which was verified by decreased MDA levels in the
ileal tissues of animals.
GSH is an endogenous antioxidant found naturally in
all animal cells. It has the potential of reacting with free
radicals ensuing secondarily to I/R, and the provisions of
glutathione precursors are protective for different types
of free-radical-mediated cellular injury [30]. Oxidants can
upregulate the transcription of gamma-glutamylcysteine
synthase genes, which is a rate-limiting enzyme for the
synthesis of GSH [31]. Melatonin’s high efficacy in re-
ducing oxidative damage may involve both receptor-
independent as well as receptor-mediated processes.
In addition to direct free radical scavenging, antioxidative
functions of melatonin may include synergistic actions
with classic antioxidants and stimulation of the synthesis
of the important intracellular antioxidant GSH [32]. Mela-
tonin stimulates glutathione peroxidase which converts
hydroperoxides, including H2O2, to water and oxygen
while oxidizing GSH [29]. Once the oxidized form of
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reductase, another enzyme whose activity is enhanced by
melatonin [30]. In this present study, the reduction of
GSH in the ileal tissue specimens seems to be a result of
oxidant injury, and the restoration of GSH in ileal tissues
of melatonin-treated animals can be attributed to these
antioxidant features of melatonin.
Conclusion
In conclusion, this study demonstrates that melatonin sig-
nificantly prevents the detrimental effects of ischemia-
reperfusion injury on the intestinal tissue in a rat model of
superior mesenteric artery occlusion. It can be speculated
that these beneficial effects of melatonin can be mainly at-
tributed to its antioxidant properties. Other findings of
this study such as decreased neutrophil activation and im-
provement of bacterial translocation seem therefore to be
secondary to those antioxidative effects. Ultimately, we be-
lieve that further clinical studies are needed to reveal the
effectiveness of melatonin as a therapeutic agent in the
clinical setting in mesenteric I/R injury.
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